National Bank of Canada FI Has $1.26 Million Stock Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)

National Bank of Canada FI trimmed its position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 1.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,776 shares of the company’s stock after selling 220 shares during the period. National Bank of Canada FI owned about 0.21% of VanEck Pharmaceutical ETF worth $1,258,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in the company. WT Wealth Management raised its holdings in VanEck Pharmaceutical ETF by 11.7% in the 4th quarter. WT Wealth Management now owns 39,613 shares of the company’s stock worth $3,223,000 after acquiring an additional 4,155 shares during the period. Independent Advisor Alliance boosted its holdings in VanEck Pharmaceutical ETF by 100.8% during the fourth quarter. Independent Advisor Alliance now owns 98,473 shares of the company’s stock valued at $7,939,000 after purchasing an additional 49,423 shares in the last quarter. Gladstone Institutional Advisory LLC bought a new position in VanEck Pharmaceutical ETF during the 4th quarter valued at about $3,818,000. Trexquant Investment LP acquired a new position in shares of VanEck Pharmaceutical ETF in the 4th quarter worth approximately $504,000. Finally, Assetmark Inc. raised its holdings in shares of VanEck Pharmaceutical ETF by 107.5% in the fourth quarter. Assetmark Inc. now owns 5,485 shares of the company’s stock valued at $446,000 after buying an additional 2,841 shares during the last quarter.

VanEck Pharmaceutical ETF Stock Performance

Shares of PPH opened at $97.30 on Friday. The firm has a market capitalization of $655.80 million, a price-to-earnings ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a 52 week low of $74.05 and a 52 week high of $99.51. The business’s fifty day moving average price is $94.96 and its two-hundred day moving average price is $91.43.

VanEck Pharmaceutical ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, July 5th. Shareholders of record on Monday, July 1st were paid a $0.3558 dividend. The ex-dividend date was Monday, July 1st.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.